Newswise WASHINGTON (Nov. 16, 2012) Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, was the recipient of a $1.7 million grant from the National Cancer Institute to study the behavior of a parasitic worm, rampant in Southeast Asia, known to cause infections that contribute to liver cancer. <\/p>\n
The idea for his project, titled Role of Live Fluke Granulin in Cholangiocarcinogenesis, was introduced to Brindley several years ago by a Thai postdoctoral student. In Thailand, the student had seen a disproportionately large amount of instances of a specific type of bile duct cancer, not common in the Western Hemisphere. It was discovered that this type of bile duct cancer, cholangiocarcinoma, is brought on by a parasitic worm that lives in uncooked fresh water fish, often present in traditional dishes in the region. The worm thrives in Southeast Asia due to unsanitary practices and conditions. The cancer caused by the worm usually results in death. <\/p>\n
With this grant we will research how a parasite could cause cancer, said Brindley. What is it doing in someones liver or bile ducts thats turning otherwise normal tissue into a tumor? <\/p>\n
The worm, which is large enough to be seen without a microscope, releases a product called granulin while navigating through the human body. In humans and other mammals, granulin is used to stimulate cells to grow and divide in order to heal a cut or a wound. When a worm secretes granulin, it seems to enhance a tumorigenic environment. <\/p>\n
In an evolutionary sense, we dont see the value to a parasite of causing a tumor to grow around it, said Brindley. If a person dies, the worm dies, too. Why would a worm induce a tumor? <\/p>\n
Over the next five years, Brindleys research team in the U.S., Australia, and Thailand will be focused on the effect this granulin secretion has on a humans liver cells. While a difficult hypothesis to prove, Brindley and his colleagues suggest that because there is a wound or lesion where the worm has passed, the worm intends to repair the damage its causing by releasing granulin. That way, in a few days the worm could return to the same place and eat the cells again. If proven, a drug or medical treatment may be developed to help with the effects of granulin on tissue growth. <\/p>\n
To interview Dr. Brindley, please contact Lisa Anderson at lisama2@gwu.edu<\/a>, 202-994-3121. <\/p>\n ### <\/p>\n About the School of Medicine and Health Sciences Founded in 1825, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nations capital and is the 11th oldest in the country. Working together in our nations capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. http:\/\/www.smhs.gwumc.edu<\/a> <\/p>\n<\/p>\n Read more: Newswise WASHINGTON (Nov. 16, 2012) Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, was the recipient of a $1.7 million grant from the National Cancer Institute to study the behavior of a parasitic worm, rampant in Southeast Asia, known to cause infections that contribute to liver cancer. The idea for his project, titled Role of Live Fluke Granulin in Cholangiocarcinogenesis, was introduced to Brindley several years ago by a Thai postdoctoral student. Continue reading
\nGW Researcher Receives $1.7 Million Grant to Study Parasitic Worm Role in Bile Duct Cancer in Southeast Asia<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"